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Abstract We have studied the effect of brefeldin A (BFA), a 
fungal toxin that interferes with coated vesicle formation, on the 
biogenesis of peroxisomes in the yeast Hansenula polymorpha. 
Addition of BFA (20 N.g/ml) to cultures of H. polymorpha 
partially inhibited the development of peroxisomes and resulted 
in the reversible accumulation of newly synthesized peroxisomal 
membrane and matrix proteins at the endoplasmic reticulum. In 
contrast, BFA did not interfere with the selective degradation of 
peroxisomes. Taken together, our data suggest that the ER plays 
a crucial role in peroxisome biogenesis in H. polymorpha, 
possibly in the biosynthesis of the peroxisomal membrane. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Peroxisomes are versatile subcellular organelles, which play 
a crucial role in various metabolic pathways [1]. In yeasts, 
peroxisomes are generally involved in the primary metabolism 
of the carbon and/or nitrogen source used for growth [2]. In 
the initial concept of peroxisome biogenesis, the organelles 
were thought to develop from the endoplasmic reticulum 
(ER). This view was predominantly based on morphological 
data which frequently showed a close association of peroxi-
somes with strands of the ER [3]. However, after the finding 
that peroxisomal proteins are synthesized in the cytosol on 
free polysomes, this concept changed into the current model 
which predicts that peroxisomes derive by fission from pre-
existing ones [4]. Recently, several proteins (peroxins) essential 
for peroxisome biogenesis have been identified [5]. Unexpect-
edly, none of them showed significant homology to compo-
nents of other protein translocation machineries (e.g. from 
mitochondria). In contrast two, Pex lp and Pex6p, are mem-
bers of the protein family of AAA-ATPases and show homol-
ogy to proteins involved in membrane fusion processes in 
eukaryotic cells (NSF/Secl8p) [6,7]. This may imply that 
vesicle-mediated processes may play a role in peroxisome bio-
genesis. In fact, several other morphological and biochemical 
findings provided indirect evidence for involvement of the ER 
in peroxisome biogenesis [8-11]. For this reason we tested 
whether brefeldin A (BFA) influences peroxisome biogenesis 
in the methylotrophic yeast Hansenula polymorpha. BFA is a 
fungal toxin which has been shown to prevent the formation 
of ER-derived coated vesicles [12,13]. We show that B F A in-
deed interferes with proper sorting of peroxisomal proteins 
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and resulted in the accumulation of these proteins at the 
ER. The details of these studies are presented in this paper. 
2. Materials and methods 
2.1. Organism and growth conditions 
Hansenula polymorpha wild-type (WT) CBS4732, NCYC495, leul.l, 
an A OX disruption mutant derived from this strain and NCYC495 
leul. 1 transformed with a plasmid encoding bacterial [S-lactamase with 
or without a PTS1 [14] were grown at 37°C on mineral media supple-
mented with 0.5% glucose or 0.5% methanol in combination with 
either 0.25% ammonium sulfate or 0.25% methylamine [15]. In 
pulse-chase experiments [35S]methionine (50 nCi-ml-1; Amersham, 
UK) was added to cultures, 15 min after the addition of BFA (20 
Hg-ml-1), incubated for 5 min and chased with 2 raM cold methio-
nine. Brefeldin A (BFA, Boehringer, Mannheim, Germany) was sup-
plemented to H. polymorpha cultures at final concentrations ranging 
from 20 to 100 ug-ml-1 from a stock solution of 10 mg-ml-1 in 
methanol. For electron microscopy, BFA-treated cells were harvested 
and immediately resuspended into fixative at 0°C in order to prevent 
reversion of the BFA effects. For biochemical analyses sodium azide 
(0.02%)) was added to the cultures 5 min before harvesting. 
2.2. Biochemical methods and electron microscopy 
Crude extract preparation [14], alcohol oxidase (AO) activity assays 
[16], determination of protein concentrations [14] and separation of 
AO monomers and octamers [17] were carried out as described before. 
Unlabeled AO protein was detected by Western blotting [18,19] using 
a-AO antibodies. 3oS-labeled AO protein was detected by fluorogra-
phy after immunoprecipitation. The precipitates were subjected to 
sodium dodecyl sulfate-polyacrylamide gel —80°C. Whole cells were 
fixed and prepared for electron microscopy and immunocytochemistry 
as described before [14]. 
3. Results 
3.1. WT H. polymorpha is sensitive to BFA 
In initial physiological experiments we observed that addi-
tion of B F A to batch cultures in the exponential growth phase 
on glucose resulted in strong retardation of growth (Fig. 1). A 
similar inhibitory effect was observed for cultures grown in 
methanol-containing media (data not shown). Electron micro-
scopical analysis of such cells revealed that B F A caused dras-
tic morphological alterations (Fig. 2). These were comparable 
to the effect of B F A on cells of a BFA-sensitive Saccharomy-
ces cerevisiae strain [20] and in particular included the devel-
opment of complex protrusions of the ER (Fig. 2). This effect 
was also observed in methanol-grown cells, al though to a 
lesser extend as in glucose-grown cells (data not shown). 
The overall morphology of other cell organelles, including 
peroxisomes, remained virtually unaffected. 
3.2. BFA results in mislocation of peroxisomal proteins to 
the ER 
In an initial experiment aimed to analyze whether BFA 
affected normal peroxisome development in H. polymorpha, 
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Fig. 1. Effect of BFA (50 ug-ml-1) on growth (measured as absorb-
ance at 660 nm, A66o) of WT H. polymorpha cells in batch cultures 
on glucose. ■, control; • . BFA-treated. 
20 ug-ml-1 BFA was added to a batch culture of the organism 
in the mid-exponential growth phase on methanol. Immuno-
cytochemical experiments revealed that alcohol oxidase (AO), 
a major peroxisomal matrix enzyme under these growth con-
ditions, showed a dual location and was localized not only in 
peroxisomes, as expected, but also at the ER and the nuclear 
envelope (Fig. 3A,B). ER-labeling was not uniform; only dis-
tinct sections of the ER were labeled. In addition, AO labeling 
was occasionally found dispersed over the cytosol (Fig. 4A). 
Two control experiments showed that the specificity of the 
a-AO antiserum used is extremely high and therefore, that the 
ER-located protein which was recognized by the a-AO anti-
body indeed represented AO protein. First, in BFA-treated 
glucose-grown cultures, in which AO synthesis is fully re-
pressed, specific AO labeling was invariably fully absent, 
both on peroxisomes and at the ER. Similar results were 
obtained in a second control experiment in which methanol-
induced cells of an AO disruption strain were treated with 
BFA (data not shown). These data unequivocally demonstrate 
that the labeling patterns obtained are indeed significant and 
specific for AO protein. 
Further immunocytochemical experiments revealed that not 
only AO, but also other peroxisomal matrix proteins (e.g. 
dihydroxyacetone synthase, catalase, amine oxidase and 
Pex8p [14]; Fig. 4C) accumulated at the ER in BFA-treated 
cells. In addition, ER-labeling was also observed when specific 
antibodies against the peroxisomal membrane proteins Pex3p 
[11] (Fig. 4B) and Pexl4p [21] (Fig. 4E) were used in these 
experiments. 
We subsequently studied the significance of the peroxisomal 
targeting signal (PTS) in the BFA-mediated sorting of matrix 
proteins to the ER. For this purpose we used H. polymorpha 
strains synthesizing bacterial |3-lactamase fused to or lacking a 
PTS1 (-AKL-COOH) [14]. The P-lactamase protein lacking a 
PTS1 was exclusively found in the cytosol, both in BFA 
treated and in untreated control cells. However, in BFA-
treated cells, synthesizing (3-lactamase-AKL, the protein was 
found both in peroxisomes and in ER-like vesicular structures 
(Fig. 4D). In untreated controls the fusion protein was only 
found inside peroxisomes. These results suggest that the BFA-
induced delivery of proteins to distinct regions of the ER is 
dependent on a functional peroxisomal targeting signal. This 
view was strengthened by experiments in which we used anti-
bodies which cross-react with cytosolic and mitochondrial 
Hsp70 [22]. Both in BFA-treated and in untreated control 
cells labeling was exclusively found at the normal location 
in the cytosol and mitochondria (Fig. 4G); ER-labeling was 
never observed. As further control also the location of acid 
phosphatase was determined. In WT H. polymorpha acid 
phosphatase is located in the vacuole and - only partially -
secreted. In untreated cells, a-acid phosphatase specific label-
ing was located on the vacuole. However, in BFA-treated cells 
labeling was also observed at the ER and the nuclear envelope 
(Fig. 4F). This finding is in line with earlier reports which 
showed that BFA treatment of eukaryotic cells results in the 
fusion of different compartments of the endomembrane sys-
tem [12,23]. 
Fig. 2. Morphology of glucose-grown H. polymorpha WT cells, incubated in the presence of BFA (50 ug-ml-1) for 1 h. Typical examples are 
given of the excessive development of ER protrusions forming complex membranous structures (A,B KMn04), which are generally continuous 
with the nuclear envelope (A, arrow). Abbreviations: ER, endoplasmic reticulum; N, nucleus; M, mitochondrion; P, peroxisome. Bar = 0.5 um. 
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Fig. 3. Immunocytochemical demonstration of AO protein in methanol-grown H. polymorpha cells, incubated with BFA (20 |ig-ml-1) for 1 h. 
Using oc-AO antibodies, labeling is evident on both peroxisomes and ER-like membranes (A,B; arrow B). The labeling is generally seen on spe-
cific strains of the ER, which are closely associated with peroxisomes and/or continuous with the nuclear envelope (compare E). C: Labeling 
on ER-like membranes 1 h after the shift of cells from glucose to methanol in the presence of BFA; D,E: 3 h after the shift both induced per-
oxisomes and ER-like strands are labeled (A-E; glutaraldehyde, uranyl acetate). 
Because BFA is known to induce fusion of different sub-
cellular compartments, AO labeling at the ER could be due to 
fusion of peroxisomes with the ER. To study the origin of the 
peroxisomal proteins accumulating at the ER, we carried out 
the following experiment. First, cells were pre-grown on meth-
anol/methylamine resulting in AO and amine oxidase (AMO)-
containing peroxisomes. The cells were collected by centrifu-
gation and incubated in mineral media lacking carbon and 
nitrogen sources (30 min, 37°C) to deplete the cells from 
AMO mRNAs. Subsequently, the cells were transferred to 
methanol/ammonium sulfate containing media supplemented 
with BFA (20 (ig-ml-1). Under these conditions AO synthesis 
is induced but AMO synthesis is fully repressed (by ammo-
nium) [24]. Immunocytochemistry revealed that after 1 h of 
incubation in the presence of BFA, AMO protein was exclu-
sively located in the peroxisomal matrix, whereas AO protein 
was again found in peroxisomes and the ER. Thus, the BFA-
mediated mislocation of AO protein does not result from 
Table 1 
Specific alcohol oxidase (AO) activities in relation to BFA concen-
trations in the growth medium 
Concentration of BFA 
(Ug-ml-1) 
Specific AO activity 
(mU-mg protein-1) 
0 
20 
50 
100 
44 
27 
14 
9 
Glucose-grown cells were transferred to methanol-containing media 
supplemented with different concentrations of BFA. After 1 h of in-
cubation, the cells were harvested and used to determine the specific 
alcohol oxidase activities. 
fusion of the ER with peroxisomes. Apparently, only newly 
synthesized peroxisomal proteins are sorted to the ER. 
We subsequently tested whether the AO protein synthesized 
during BFA treatment is quantitatively mistargeted to the ER. 
For this purpose cells from exponentially growing cultures on 
glucose were transferred to methanol-containing media sup-
plemented with BFA at concentrations ranging from 20 to 100 
Ug-ml-1. In the glucose-grown inoculum cells only one or few 
small peroxisomes are present, which lack AO protein because 
of glucose repression. Upon transfer to methanol-medium AO 
synthesis is induced (see also Table 1). After 1 h of incubation 
in the presence of BFA newly synthesized AO protein was 
found at the ER (Fig. 3C). However, after 3 h AO protein 
was detected inside peroxisomes as well (Fig. 3D,E). Thus, 
BFA induces the mistargeting of only a portion of the newly 
synthesized peroxisomal matrix proteins. 
The reversibility of BFA-induced mistargeting of peroxiso-
mal proteins was evident after analysis of cells which were 
collected by centrifugation and resuspended in fresh medium 
without BFA. Already after 10 min of incubation in fresh 
media AO labeling at the ER was strongly reduced and in-
variably undetectable after 30 min of incubation in fresh me-
dia. In these cells AO protein was again only found inside 
peroxisomes (data not shown). 
In order to determine the biochemical properties of AO 
synthesized in the presence of BFA, we analyzed AO protein 
in crude extracts prepared from cells pre-grown on glucose 
and shifted for 1 h to methanol-medium in the presence of 
BFA (20-100 (j,g-ml-1). Enzyme activity measurements re-
vealed that in BFA-treated cells the AO activities were lower 
compared to those found in extracts from identically grown 
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Fig. 4. Immunocytochemical localization studies in BFA-treated H. polymorpha cells using various antibodies against H. polymorpha proteins. 
Apart from peroxisome- and ER-bound labeling (shown in Fig. 3), a-AO specific labeling was occasionally also found in the cytosol (A). The 
integral peroxisomal membrane protein Pex3p (B), the membrane associated protein Pex8p (C) and Pexl4p (E) were localized both on the per-
oxisomal membrane and at the ER. D: BFA-treated cells which synthesize bacterial (3-lactamase fused to a PTS1. Using a-P-lactamase antibod-
ies labeling is observed both on peroxisomes and ER. Using a-acid phosphatase antibodies labeling was found in the vacuole and the nuclear 
envelope (F). In controls, using a-hsp70 antibodies which recognizes both cytosolic and mitochondrial H. polymorpha hsp70s labeling was con-
fined to mitochondria and the cytosol (G). 
control cells (Table 1). We then studied whether BFA affects 
the assembly of octameric AO enzyme. As shown in Fig. 5A, 
both in BFA-treated cells and untreated control cells bulk of 
the AO protein synthesized was in the octameric conforma-
tion. 
Pulse chase experiments revealed that also the kinetics of 
AO oligomerization were identical in BFA-treated and un-
treated controls (Fig. 5B). Thus, BFA does not significantly 
affect oligomerization of AO. The reduced AO enzyme activ-
ities in BFA-treated cells are most probably due to decreased 
AO expression levels, possibly caused by the retardation of 
growth (see also Fig. 1). 
questration of the organelles to be degraded from the cytosol 
before fusion with the vacuole where degradation occurs. To 
study whether BFA affects this process, 20 ug-ml-1 BFA was 
added to a batch culture in the mid-exponential growth phase 
on methanol, incubated for 5 min and subsequently supple-
mented with excess glucose. Enzyme activity measurements 
and Western blot analysis indicated that AO activity and pro-
tein rapidly declined both in BFA-treated and in untreated 
control cultures. This result was confirmed in subsequent elec-
tron microscopical analyses, which revealed that glucose-in-
duced peroxisome degradation was not affected by BFA (data 
not shown). 
3.3. Glucose-induced peroxisome degradation is not prevented 
by BFA 
In H. polymorpha a shift of cells from methanol to excess 
glucose results in the active degradation of peroxisomes by 
autophagocytosis [25]. The initial stage of this process is se-
4. Discussion 
In this study we showed that BFA affects protein sorting to 
peroxisomes resulting in the accumulation of these proteins at 
the ER. Morphological and biochemical effects caused by 
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Fig. 5. Separation of octameric (fractions 5, 6) and monomeric AO 
(fraction 2) protein by sucrose density centrifugation of crude ex-
tracts prepared from cells treated with BFA (20 irg-ml-1; +) or 
from untreated controls (—). A: Cells were shifted from glucose- to 
methanol-containing media either in the presence (+) or absence (—) 
of BFA and incubated for 1 h. Crude extracts were subjected to su-
crose-density centrifugation. Western blots, prepared from the differ-
ent fractions decorated using a-AO antibodies, reveal that both in 
the absence and presence of BFA almost all AO protein found is 
octameric. Equal volumes of each fraction were loaded per lane. To 
determine the kinetics of AO oligomerization a pulse-chase experi-
ment was performed (B). BFA was added to cells growing exponen-
tially on methanol. After 15 min of incubation, a pulse of 
[35S]methionine was given for 5 min. After 40 min of incubation 
samples were taken and used to prepare sucrose-gradients. Equal 
volumes of each fraction were subjected to immunoprecipitation us-
ing a-AO antibodies, followed by SDS-PAGE and fluorography. 
The results indicate that the kinetics of AO oligomerization were 
not significantly altered in BFA-treated cell. 
BFA are, without exceptions, ascribed to the inhibition of 
binding of cytosolic coat proteins to membranes of the ER 
and Golgi. Binding of coat proteins to membranes requires a 
small GTP-binding protein, designated ADP-ribosylation fac-
tor (ARF; reviewed in [26]). Exchange of the ARF-bound 
GDP for GTP results in the binding of ARF and cytosolic 
coat proteins to membranes. BFA inhibits the GDP/GTP ex-
change activity for ARF and, as a consequence, prevents the 
formation of coated vesicles [12,13]. It is likely that BFA-
induced accumulation of peroxisomal proteins at the ER 
also results from the prevention of the formation of vesicles 
and that a BFA-sensitive ARF-like protein is involved. It has 
been shown before that indeed different organelle-specific tar-
get proteins for BFA exist in eukaryotic cells [27]. In Saccha-
romyces cerevisiae three ARF genes have been identified; two 
of them are involved in protein secretion, whereas the func-
tion of the third one (ARF3) remained elusive so far [28]. In 
fact, ARF3 would be a possible candidate to encode an ARF 
involved in peroxisome biogenesis, because it shares proper-
ties with genes involved in peroxisome biogenesis {PEX 
genes): the expression of ARF3 is repressed by glucose and 
deletion of the gene is not lethal [28]. We have not been able 
to unequivocally determine, whether the BFA-induced mistar-
geted peroxisomal matrix proteins are actually located in the 
ER lumen or bound to its cytosolic surface. Protease protec-
tion assays, performed on subcellular fractions, were invaria-
bly poorly reproducible and the outcome difficult to interpret. 
Part of these problems might be explained by the fact that 
BFA only partially blocked peroxisomal matrix protein im-
port and that the effect of BFA was highly reversible. This 
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might explain why biochemically no significant effects of BFA 
could be demonstrated (e.g. activation and oligomerization of 
AO were unaltered upon BFA-treatment). We also found no 
indications that mistargeted peroxisomal matrix proteins were 
modified (e.g. glycosylated), a process which is likely to occur 
when these proteins would enter the ER lumen. This therefore 
suggests that the matrix proteins most probably were bound 
to the cytosolic surface of the ER membrane. 
Our present view on the principles of peroxisome biogenesis 
in H. polymorpha are included in the model, depicted in Fig. 
6. This model predicts that vesicles are formed at specialized 
regions of the ER which fuse with peroxisomes resulting in 
growth of the organelle and incorporation of membrane com-
ponents (proteins/lipids). We speculate that only a subset of 
the peroxisomal membrane proteins (PMP) are sorted to per-
oxisomes via the ER (PMB: peroxisomal membrane proteins 
involved in peroxisome biogenesis). When the formation of 
these vesicles is blocked by BFA, these PMBs will predomi-
nantly accumulate at the ER (e.g. Pex3p and Pexl4p). Likely 
PMB candidates include H. polymorpha Pex3p and Pexl4p, 
which were shown to accumulate at the ER when they are 
overproduced [11,21]. Moreover, S. cerevisiae Pas21p was de-
livered to the plasma membrane when the last 55 amino acids 
were deleted [10]. One possible explanation for this phenom-
enon is that Pas21p is initially targeted to the ER and sub-
sequently delivered to peroxisomes by vesicular transport; in 
this process the last 55 amino acids may be essential for a 
correct routing to peroxisomes and/or to prevent that the 
protein enters the secretory pathway. We anticipate that not 
Nucleus 
PMKs 
Fig. 6. Hypothetical model of peroxisome biogenesis in H. polymor-
pha. Peroxisomal proteins are synthesized on free polysomes in the 
cytosol. Membrane proteins involved in peroxisome biogenesis 
(PMBs, e.g. HpPex3p) are sorted to the ER and incorporated into 
vesicles which are transported to the growing peroxisome. Mem-
brane proteins involved in peroxisome functioning (PMFs, e.g. 
transporters) may be sorted directly to the organelle. Matrix pro-
teins (MP) are recognized by PTS-receptor proteins in the cytosol 
and subsequently either transported directly to a peroxisomal dock-
ing site (I), a putative transport vesicle (II) or the ER (III). After 
import into the peroxisomal matrix the receptor and its cargo mole-
cule dissociate followed by recycling of the receptor. 
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all PMPs are sorted via the ER. Functional membrane pro-
teins (e.g. proteins involved in transport of solutes, for in-
stance Candida boidinii PMP47 [29]) may be sorted directly 
from the cytosol to the peroxisomal membrane (PMF: 
peroxisomal membrane protein involved in peroxisome func-
tioning). 
For sorting of peroxisomal matrix proteins (designated MP) 
our model envisages different possibilities. Matrix proteins 
may, upon synthesis in the cytosol and recognition by a 
PTS-receptor be targeted directly to the peroxisomal mem-
brane (pathway I), to a transport vesicle (pathway II) or to 
the ER (pathway III). Several recent papers favour pathway I 
(reviewed in [30]). In this concept the PTS-receptor, bound to 
its cargo, interacts with the peroxisomal membrane at a dock-
ing site. For the subsequent step two alternative pathways 
have been proposed. One predicts that receptor/cargo complex 
enters the peroxisomal matrix, where dissociation occurs. The 
PTS-receptor is then exported to the cytosol, from where it 
can shuttle the next protein molecule into the organelle (see 
Fig. 6). The alternative is that the receptor already dissociates 
from the PTS protein at an earlier stage, namely at the per-
oxisomal surface. In this model the receptor shuttles between 
the cytosol and the docking site on the peroxisomal surface 
(see [30]). For H. polymorpha evidence has been obtained that 
the PTS 1-receptor enters the organellar matrix [31]. Two pu-
tative docking proteins, Pexl3p and Pexl4p, have recently 
been identified [21,32-35]. These proteins have been shown 
to physically interact with the PTS-receptors. As a conse-
quence they can indirectly bind PTS-cargo proteins. We pro-
pose that Pexl3p and Pexl4p are PMBs and thus accumulate 
at the ER upon BFA-treatment, because vesicle formation is 
prevented. Indeed, we found Pexl4p at the ER membrane in 
BFA-treated H. polymorpha cells; information on HpPexl3p 
is not available, because the gene has not been identified yet. 
If pathway I (Fig. 6) is in fact the normal import pathway, 
why would matrix proteins become ER-associated in BFA-
treated cells? One possibility is that the accumulation of 
Pexl4p at the ER upon BFA-treatment may result in the 
formation of an artificial PTS-receptor docking site. This 
would readily explain why both peroxisomal membrane and 
matrix proteins accumulate at the ER under these conditions. 
Moreover, it would also explain why only a portion of the 
newly synthesized proteins are delivered to the ER, because 
next to BFA-induced docking sites at the ER, pre-existing 
peroxisomal docking sites are available as well. 
An alternative explanation for the ER location of matrix 
proteins in BFA-treated cells (pathways III, Fig. 6) includes 
that these proteins are not transported directly, but are deliv-
ered to the target organelle together with membrane compo-
nents. This view is in line with the notion that large amounts 
of matrix proteins can only be incorporated in the organelle 
when simultaneously the organellar volume is increased. In 
this concept peroxisomal matrix proteins are first targeted to 
the ER and accumulate with PMBs in or at transport vesicles, 
which migrate to developing peroxisomes. In these processes 
Pexlp and Pex6p - two AAA-ATPases essential for peroxi-
some biogenesis in yeasts - may play a role. According to this 
model inhibition of vesicle formation by BFA obviously re-
sults in accumulation of matrix proteins at/in the ER. Ffypo-
thetically, matrix proteins could of course also interact with or 
be incorporated in the transport vesicle after it has been 
formed at the ER (pathway II). 
Our model implies that successful import of components 
into peroxisomes is only dependent on the availability of an 
exposed PTS and therefore also offers an explanation for the 
finding that oligomeric proteins and even gold particles coated 
with PTS-peptides are incorporated into peroxisomes [36-38]. 
The molecular mechanisms of import (e.g. fusion events or 
phagocytosis-like processes) are still completely unknown. 
Which of the three pathways for matrix protein import 
proposed in Fig. 6 is correct is also speculative. However, 
all include a temporal association of matrix proteins via 
PTS-receptors with PMBs, which are sorted to peroxisomes 
via the ER. As a consequence a block in the formation of ER-
derived vesicles will invariable result in accumulation of mem-
brane and matrix proteins at the ER, independent of which 
pathway for matrix proteins is actually correct. 
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